Influenza virus vaccine, Attenuated live, Intranasal (MedImmune)

鼻喷减毒活流感病毒疫苗(MedImmune)

Report date: 2026/04/21 20:00:18

Base Information

Drug NameInfluenza virus vaccine, Attenuated live, Intranasal (MedImmune)
Drug Alias NameFluenzFluMistCAIV-T
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveNeoplasmsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/06/17
Country/TerritoryCzechiaBelgiumUnited States +[11
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active IndicationsPulmonary Disease, Chronic ObstructiveInfluenza, Human
Inactive IndicationsNeoplasms

Other Information

ATC CodeJ07BB03
Related LinksWikipedia